Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
After months of waiting, the world finally has its first coronavirus drug to be fully approved by a major regulator. On Thursday, the U.S. Food and Drug Administration (FDA) granted approval to Gilead Sciences' (NASDAQ: GILD) remdesivir -- sold under the brand name Veklury -- to treat the illness in patients 12 years of age and older in cases requiring hospitalization.
Remdesivir had been in use previously under an Emergency Use Authorization (EUA), which was granted in May from the same regulator. It holds the same status in around 50 other countries around the world.
Image source: Getty Images.
Source Fool.com
